SGLT2i reduces outcomes in HFmrEF and HFpEF regardless of glycemic status

3' education - Sep. 22, 2022 - Prof. Pardeep Jhund, MD, PhD - Glasgow, UK

Educational information

This video was recorded during the EASD annual meeting 2022 in Stockholm, Sweden.

Faculty

Pardeep Jhund is Professor of Cardiology and Epidemiology at the University of Glasgow and an honorary consultant cardiologist at the Queen Elizabeth University Hospital, Glasgow, UK.

Disclosures

This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.

Read our summary of the DELIVER trial

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.